Florida Gov. Ron DeSantis (R) is again lashing out at marijuana legalization as voters prepare to decide on a ballot initiative in November, warning that the reform would negatively impact quality of life in the state. The governor, who has mocked legalization repeatedly in a series of recent comments,... Read more

The Drug Enforcement Administration’s (DEA) decision to reschedule marijuana is being met with relief, elation, commendations—and criticism from advocates who have been quick to point out that the modest reform does not mean cannabis will be federally legalized or that President Joe Biden’s campaign pledge to at least decriminalize... Read more

Senate Majority Leader Chuck Schumer (D-NY) says that while the Drug Enforcement Administration’s (DEA) reported decision to propose marijuana rescheduling is a “historic step forward,” he remains “strongly committed” to advancing cannabis banking and legalization legislation this session. As DEA prepares to formally initiate rulemaking to move cannabis from... Read more

A new study on effects of frequent marijuana use challenges a number of cannabis stereotypes, with researchers finding no association with paranoia or decreased motivation among habitual users. They also found no evidence that marijuana consumption causes a hangover the next day. Among the results that authors deemed “surprising,”... Read more

Senate Minority Leader Mitch McConnell (R-KY) “continues to oppose marijuana banking,” a spokesperson for his office told Marijuana Moment on Monday. And another Senate source says that GOP leadership’s opposition to the reform as a policy matter is obstructing the path to advancing the cannabis measure as part of... Read more

Officials with the nation’s top marijuana prohibitionist advocacy group say they are hearing that the results of the Drug Enforcement Administration’s (DEA) cannabis scheduling review will be announced “very soon,” possibly as soon as “today or tomorrow.” DEA has spent the last eight months considering a U.S. Department of... Read more

A new federal funding opportunity from the National Institutes of Health (NIH) will use $8.4 million to support clinical trials on the safety and efficacy of psychedelic-assisted therapy to treat chronic pain in older adults. An NIH notice of funding opportunity posted on Wednesday says the research can include... Read more